688617 惠泰医疗
已收盘 04-30 15:00:00
资讯
新帖
简况
惠泰医疗:4月18日召开业绩说明会,投资者参与
证券之星 · 04-30 23:56
惠泰医疗:4月18日召开业绩说明会,投资者参与
惠泰医疗创历史新高 高端医疗器械首发会举行
智选洞察 · 04-30 10:42
惠泰医疗创历史新高 高端医疗器械首发会举行
惠泰医疗获融资买入0.23亿元,近三日累计买入0.37亿元
金融界 · 04-30 08:14
惠泰医疗获融资买入0.23亿元,近三日累计买入0.37亿元
惠泰医疗(688617)4月29日主力资金净买入3559.96万元
证券之星 · 04-30 07:51
惠泰医疗(688617)4月29日主力资金净买入3559.96万元
惠泰医疗:控股股东变为深迈控
每日经济新闻 · 04-29 22:25
惠泰医疗:控股股东变为深迈控
迈瑞医疗(300760.SZ)取得惠泰医疗控制权
智通财经 · 04-29 19:05
迈瑞医疗(300760.SZ)取得惠泰医疗控制权
惠泰医疗04月29日收跌2.44% 主力资金逆市抢筹
自选股智能写手 · 04-29
惠泰医疗04月29日收跌2.44% 主力资金逆市抢筹
惠泰医疗(688617):业绩再超预期 心血管龙头逐渐成形
中国国际金融股... · 04-29
惠泰医疗(688617):业绩再超预期 心血管龙头逐渐成形
迈瑞医疗(300760)2023年报及2024年一季报点评:业绩增长稳健 收购惠泰医疗进入心血管赛道
光大证券 · 04-28
迈瑞医疗(300760)2023年报及2024年一季报点评:业绩增长稳健 收购惠泰医疗进入心血管赛道
惠泰医疗(688617):经营稳健 利润加速释放
东吴证券 · 04-26
惠泰医疗(688617):经营稳健 利润加速释放
惠泰医疗04月26日主力资金流出379万元 连续3日减仓
自选股智能写手 · 04-26
惠泰医疗04月26日主力资金流出379万元 连续3日减仓
惠泰医疗获东吴证券买入评级,经营稳健,利润加速释放
金融界 · 04-26
惠泰医疗获东吴证券买入评级,经营稳健,利润加速释放
东吴证券:给予惠泰医疗买入评级
证券之星 · 04-26
东吴证券:给予惠泰医疗买入评级
惠泰医疗获太平洋买入评级,电生理手术量增速强劲,血管介入新品迭出
金融界 · 04-26
惠泰医疗获太平洋买入评级,电生理手术量增速强劲,血管介入新品迭出
太平洋:给予惠泰医疗买入评级
证券之星 · 04-26
太平洋:给予惠泰医疗买入评级
图解惠泰医疗一季报:第一季度单季净利润同比增36.48%
证券之星 · 04-25
图解惠泰医疗一季报:第一季度单季净利润同比增36.48%
惠泰医疗(688617)3月31日股东户数0.35万户,较上期增加12.27%
证券之星 · 04-25
惠泰医疗(688617)3月31日股东户数0.35万户,较上期增加12.27%
惠泰医疗:2024年第一季度净利润约1.40亿元
每日经济新闻 · 04-25
惠泰医疗:2024年第一季度净利润约1.40亿元
惠泰医疗(688617.SH)发布一季度业绩,净利润1.4亿元 同比增加36.48%
智通财经 · 04-25
惠泰医疗(688617.SH)发布一季度业绩,净利润1.4亿元 同比增加36.48%
医疗耗材概念盘中拉升,惠泰医疗涨2.80%
自选股智能写手 · 04-24
医疗耗材概念盘中拉升,惠泰医疗涨2.80%
暂无数据
公司概况
公司名称:
深圳惠泰医疗器械股份有限公司
所属行业:
专用设备制造业
上市日期:
2021-01-07
主营业务:
深圳惠泰医疗器械股份有限公司的主营业务为心血管介入医疗器械的研发、生产和销售;主要产品是电生理、冠脉通路、外周血管介入、非血管介入医疗器械。公司的电生理电极导管和射频消融电极导管均为国内首个获批上市的国产产品,先发优势助力公司成为国内电生理市场中国生产厂商的龙头企业。
发行价格:
74.46
{"stockData":{"symbol":"688617","market":"SH","secType":"STK","nameCN":"惠泰医疗","latestPrice":503.68,"timestamp":1714460400000,"preClose":481.61,"halted":0,"volume":455186,"delay":0,"floatShares":66861400,"shares":66861400,"eps":8.5458,"marketStatus":"已收盘","marketStatusCode":5,"change":22.07,"latestTime":"04-30 15:00:00","open":478.01,"high":507.97,"low":477.02,"amount":227000000,"amplitude":0.0643,"askPrice":503.85,"askSize":2,"bidPrice":503.68,"bidSize":2,"shortable":0,"etf":0,"ttmEps":8.5458,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1714959000000},"adr":0,"adjPreClose":481.61,"symbolType":"stock_kcb","openAndCloseTimeList":[[1714440600000,1714447800000],[1714453200000,1714460400000]],"highLimit":529.77,"lowLimit":433.45,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":66861357,"pbRate":16.42,"roa":"--","roe":"7.08%","epsLYR":8.04,"committee":-0.090909,"marketValue":33677000000,"floatMarketCap":33677000000,"peRate":58.938893,"changeRate":0.0458,"turnoverRate":0.0068,"status":0,"nextConnectDate":"根据港交所公布的数据,今日已停止北向交易,下一个交易日为北京时间 2024-05-06。","afterMarket":{"amount":0,"volume":0,"close":503.68,"buyVolume":0,"sellVolume":0,"time":1714462439505,"indexStatus":"已收盘 04-30 15:30:00","preClose":481.61}},"requestUrl":"/m/hq/s/688617/tweets","defaultTab":"tweets","newsList":[{"id":"2432745793","title":"惠泰医疗:4月18日召开业绩说明会,投资者参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2432745793","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2432745793?lang=zh_cn&edition=full","pubTime":"2024-04-30 23:56","pubTimestamp":1714492570,"startTime":"0","endTime":"0","summary":"证券之星消息,2024年4月30日惠泰医疗发布公告称公司于2024年4月18日召开业绩说明会。锚定球囊入院较去年有明显改善。公司的毛利率受产品出厂价、产品组合及产品成本等因素的影响。惠泰医疗2024年一季报显示,公司主营收入4.55亿元,同比上升30.2%;归母净利润1.4亿元,同比上升36.48%;扣非净利润1.37亿元,同比上升51.59%;负债率19.36%,投资收益334.66万元,财务费用-246.28万元,毛利率72.01%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404302358348b66e0ae&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404302358348b66e0ae&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2431073384","title":"惠泰医疗创历史新高 高端医疗器械首发会举行","url":"https://stock-news.laohu8.com/highlight/detail?id=2431073384","media":"智选洞察","top":-1,"share":"https://www.laohu8.com/m/news/2431073384?lang=zh_cn&edition=full","pubTime":"2024-04-30 10:42","pubTimestamp":1714444967,"startTime":"0","endTime":"0","summary":"消息解读2024年4月28日,中关村论坛迎来了高精尖技术产品首发会“高端医疗器械专场”活动,8个《百项新技术新产品榜单》高端医疗器械领域的优秀参评项目,进行了现场首发。北向资金方面,惠泰医疗04月29日获得北向资金减持0.91万股,截至04月29日,北向资金当前共持有惠泰医疗246.51万股,市值12.47亿元,持股占流通股比为3.68%。主营业务及业绩惠泰医疗公司主营业务为电生理和血管介入医疗器械的研发、生产和销售。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404301044347a578f34&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404301044347a578f34&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2431803895","title":"惠泰医疗获融资买入0.23亿元,近三日累计买入0.37亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2431803895","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2431803895?lang=zh_cn&edition=full","pubTime":"2024-04-30 08:14","pubTimestamp":1714436084,"startTime":"0","endTime":"0","summary":"4月29日,沪深两融数据显示,惠泰医疗获融资买入额0.23亿元,居两市第508位,当日融资偿还额0.12亿元,净买入1031.36万元。最近三个交易日,25日-29日,惠泰医疗分别获融资买入0.05亿元、0.09亿元、0.23亿元。融券方面,当日融券卖出0.70万股,净买入0.31万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404300816108b63f17e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404300816108b63f17e&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2431872333","title":"惠泰医疗(688617)4月29日主力资金净买入3559.96万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2431872333","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2431872333?lang=zh_cn&edition=full","pubTime":"2024-04-30 07:51","pubTimestamp":1714434705,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年4月29日收盘,惠泰医疗报收于481.61元,下跌2.44%,换手率0.85%,成交量5666.0手,成交额2.74亿元。近5日资金流向一览见下表:惠泰医疗融资融券信息显示,融资方面,当日融资买入2281.02万元,融资偿还1249.66万元,融资净买入1031.36万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024043000013901.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2431609178","title":"惠泰医疗:控股股东变为深迈控","url":"https://stock-news.laohu8.com/highlight/detail?id=2431609178","media":"每日经济新闻","top":-1,"share":"https://www.laohu8.com/m/news/2431609178?lang=zh_cn&edition=full","pubTime":"2024-04-29 22:25","pubTimestamp":1714400705,"startTime":"0","endTime":"0","summary":"每经AI快讯,惠泰医疗(SH 688617,收盘价:481.61元)4月29日晚间发布公告称,公司第二届董事会、监事会改组工作已完成,公司控制权变更完成,公司控股股东变更为深迈控。2023年1至12月份,惠泰医疗的营业收入构成为:医疗器械占比99.49%。截至发稿,惠泰医疗市值为322亿元。道达号(daoda1997)“个股趋势”提醒:1. 惠泰医疗近30日内北向资金持股量增加89.43万股,占流通股比例增加1.34%;2. 近30日内无机构对惠泰医疗进行调研。每经头条(nbdtoutiao)——成交量全国第一的城市,住房限购全面取消!啥信号?(记者 蔡鼎)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042922373787bfccf3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042922373787bfccf3&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2431834731","title":"迈瑞医疗(300760.SZ)取得惠泰医疗控制权","url":"https://stock-news.laohu8.com/highlight/detail?id=2431834731","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2431834731?lang=zh_cn&edition=full","pubTime":"2024-04-29 19:05","pubTimestamp":1714388758,"startTime":"0","endTime":"0","summary":"智通财经APP讯,迈瑞医疗(300760.SZ)公告称,截至本公告日,成正辉持有惠泰医疗1251.93万股股份,占惠泰医疗总股本的18.72%,持有表决权比例为8.72%。公司通过深迈控及其一致行动人珠海彤升合计持有惠泰医疗1645.56万股股份,占惠泰医疗总股本的24.61%,持有表决权比例为24.61%。惠泰医疗第二届董事会、监事会改组工作已完成,公司取得惠泰医疗控制权。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1114674.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2431004411","title":"惠泰医疗04月29日收跌2.44% 主力资金逆市抢筹","url":"https://stock-news.laohu8.com/highlight/detail?id=2431004411","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2431004411?lang=zh_cn&edition=full","pubTime":"2024-04-29 15:18","pubTimestamp":1714375121,"startTime":"0","endTime":"0","summary":"04月29日, 惠泰医疗股价跌2.44%,报收481.61元,成交金额2.74亿元,换手率0.85%,振幅4.55%,量比1.36。惠泰医疗今日主力资金净流入3680万元,上一交易日主力净流出379万元。该股近5个交易日上涨3.07%,主力资金累计净流入966万元,其中2个交易日为股价下跌时净流入;近20日主力资金累计净流出8506万元,其中净流出天数为12日。该行业中净流入前三个股分别为惠泰医疗、奥泰生物、欧普康视。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404291531308b60caa7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404291531308b60caa7&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2431997079","title":"惠泰医疗(688617):业绩再超预期 心血管龙头逐渐成形","url":"https://stock-news.laohu8.com/highlight/detail?id=2431997079","media":"中国国际金融股...","top":-1,"share":"https://www.laohu8.com/m/news/2431997079?lang=zh_cn&edition=full","pubTime":"2024-04-29 00:00","pubTimestamp":1714320000,"startTime":"0","endTime":"0","summary":"由于冠脉/外周毛利率持续提升,以及各项费用控制良好,2023 年和1Q24 利润端超出我们的预期。随着各省电生理集采陆续落地实施,我们预计公司调整出厂价带来的毛利率下降基本结束,未来有望随着降本增效和新品放量回升。2023 年冠脉通路收入7.91 亿元,同比+39%,毛利率同比+2.5 ppt 至71.9%;外周介入收入2.56 亿元,同比+40%,毛利率同比+3.1 ppt 至74.8%。我们判断1Q24 冠脉和外周收入分别有30%/40%左右的同比增长,伴随毛利率的进一步提升。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404291320278b605aa3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404291320278b605aa3&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430926054","title":"迈瑞医疗(300760)2023年报及2024年一季报点评:业绩增长稳健 收购惠泰医疗进入心血管赛道","url":"https://stock-news.laohu8.com/highlight/detail?id=2430926054","media":"光大证券","top":-1,"share":"https://www.laohu8.com/m/news/2430926054?lang=zh_cn&edition=full","pubTime":"2024-04-28 20:35","pubTimestamp":1714307705,"startTime":"0","endTime":"0","summary":"事件:公司发布2023 年报与2024 年一季报。2024 年第一季度,公司实现营业收入93.73 亿元,同比增长12.06%;实现归母净利润31.60 亿元,同比增长22.90%。2023 年营收增长主要源于国内医院常规诊疗活动迅速恢复、海外高端客户群加速突破。截至2024 Q1,公司共获授权专利4,945 件,其中发明专利授权2,346 件。同时,在24 年第一季度,公司推进对心血管细分领域龙头企业惠泰医疗的控制权收购,进入心血管赛道将为公司培育新的增长极,为公司长期稳健发展助力。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404282035148b5de31b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404282035148b5de31b&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430624373","title":"惠泰医疗(688617):经营稳健 利润加速释放","url":"https://stock-news.laohu8.com/highlight/detail?id=2430624373","media":"东吴证券","top":-1,"share":"https://www.laohu8.com/m/news/2430624373?lang=zh_cn&edition=full","pubTime":"2024-04-26 15:34","pubTimestamp":1714116867,"startTime":"0","endTime":"0","summary":"2024Q1 收入符合预期,利润超我们预期。费用控制良好,毛利率及净利率环比提升。2024Q1 实现毛利率72.01%,净利率30.28%,2023Q4 毛利率70.95%,净利率28.77%。完成股份转让,迈瑞控股有望在二季度产生协同。截至4 月26 日,深迈控直接持有公司约1412 万股股份,占公司总股本的21.12%,深迈控的一致行动人珠海彤升持有公司2,335,296 股股份,占公司总股本的3.49%,深迈控及其一致行动人珠海彤升合计持有公司约1646 万股股份,占公司总股本的24.61%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404261534318b5617a0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404261534318b5617a0&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430437822","title":"惠泰医疗04月26日主力资金流出379万元 连续3日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2430437822","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2430437822?lang=zh_cn&edition=full","pubTime":"2024-04-26 15:19","pubTimestamp":1714115947,"startTime":"0","endTime":"0","summary":"04月26日, 惠泰医疗股价涨4.17%,报收493.68元,成交金额2.76亿元,换手率0.85%,振幅5.58%,量比1.56。惠泰医疗今日主力资金净流出379万元,连续3日净流出,上一交易日主力净流出1999万元,今日环比减少81.04%。近一年数据显示,该股主力连续3日净流出后,次日下跌概率为28.57%,平均跌幅为1.94%。该股近5个交易日上涨8.59%,主力资金累计净流出3738万元,其中1个交易日为股价下跌时净流入;近20日主力资金累计净流出1.33亿元,其中净流出天数为13日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404261536218b5619d4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404261536218b5619d4&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430243781","title":"惠泰医疗获东吴证券买入评级,经营稳健,利润加速释放","url":"https://stock-news.laohu8.com/highlight/detail?id=2430243781","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2430243781?lang=zh_cn&edition=full","pubTime":"2024-04-26 15:14","pubTimestamp":1714115676,"startTime":"0","endTime":"0","summary":"4月26日,惠泰医疗获东吴证券买入评级,近一个月惠泰医疗获得4份研报关注。研报预计东吴证券将公司24-26年归母净利润由7.04/9.10/11.63亿元调整至7.23/9.76/13.06亿元,对应估值为44/32/24X。研报认为,惠泰医疗2024年一季度实现营收4.55亿元,同比增长30.20%,其中,归母净利润达到1.40亿元,增长36.48%,扣非归母净利润为1.37亿元,增长51.59%。因此东吴证券认为2024Q1的收入符合预期,利润超出预期。此外,外周新品胸主动脉覆膜支架国内上市,进一步增强了惠泰医疗的外周竞争力。风险提示:行业政策发生重大变更风险,产品销售推广不及预期风险。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042615145687b25fe3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042615145687b25fe3&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430102092","title":"东吴证券:给予惠泰医疗买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2430102092","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2430102092?lang=zh_cn&edition=full","pubTime":"2024-04-26 15:03","pubTimestamp":1714115010,"startTime":"0","endTime":"0","summary":"东吴证券股份有限公司朱国广近期对惠泰医疗进行研究并发布了研究报告《2024年一季报点评:经营稳健,利润加速释放》,本报告对惠泰医疗给出买入评级,当前股价为493.68元。 盈利预测与投资评级:考虑公司外周新品放量,我们将公司24-26年归母净利润由7.04/9.10/11.63亿元调整至7.23/9.76/13.06亿元,对应估值为44/32/24X,维持“买入”评级。最新盈利预测明细如下:该股最近90天内共有17家机构给出评级,买入评级12家,增持评级5家;过去90天内机构目标均价为484.68。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042600027759.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2430292276","title":"惠泰医疗获太平洋买入评级,电生理手术量增速强劲,血管介入新品迭出","url":"https://stock-news.laohu8.com/highlight/detail?id=2430292276","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2430292276?lang=zh_cn&edition=full","pubTime":"2024-04-26 11:14","pubTimestamp":1714101261,"startTime":"0","endTime":"0","summary":"4月26日,惠泰医疗获太平洋买入评级,近一个月惠泰医疗获得3份研报关注。研报预计公司2024-2026年营业收入分别为22.23亿/30.08亿/39.68亿元,同比增速分别为35%/35%/32%;归母净利润分别为6.89亿/9.34亿/12.37亿元,分别增长29%/36%/32%。研报认为,公司积极拓展国内外市场,产品覆盖率进一步提高。同时,电生理手术量增速强劲,新产品如血管介入等不断出现。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404261114268b5552b5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404261114268b5552b5&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430614294","title":"太平洋:给予惠泰医疗买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2430614294","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2430614294?lang=zh_cn&edition=full","pubTime":"2024-04-26 10:59","pubTimestamp":1714100372,"startTime":"0","endTime":"0","summary":"太平洋证券股份有限公司谭紫媚近期对惠泰医疗进行研究并发布了研究报告《惠泰医疗点评报告:电生理手术量增速强劲,血管介入新品迭出》,本报告对惠泰医疗给出买入评级,当前股价为483.5元。维持“买入”评级。最新盈利预测明细如下:该股最近90天内共有17家机构给出评级,买入评级12家,增持评级5家;过去90天内机构目标均价为484.68。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042600025825.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2430479702","title":"图解惠泰医疗一季报:第一季度单季净利润同比增36.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430479702","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2430479702?lang=zh_cn&edition=full","pubTime":"2024-04-25 17:32","pubTimestamp":1714037532,"startTime":"0","endTime":"0","summary":"证券之星消息,惠泰医疗2024年一季报显示,公司主营收入4.55亿元,同比上升30.2%;归母净利润1.4亿元,同比上升36.48%;扣非净利润1.37亿元,同比上升51.59%;负债率19.36%,投资收益334.66万元,财务费用-246.28万元,毛利率72.01%。财报数据概要请见下图:以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042517404387ae9fba&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042517404387ae9fba&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430186476","title":"惠泰医疗(688617)3月31日股东户数0.35万户,较上期增加12.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430186476","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2430186476?lang=zh_cn&edition=full","pubTime":"2024-04-25 17:10","pubTimestamp":1714036213,"startTime":"0","endTime":"0","summary":"证券之星消息,近日惠泰医疗披露,截至2024年3月31日公司股东户数为3486.0户,较2月29日增加381.0户,增幅为12.27%。在医疗器械行业个股中,惠泰医疗股东户数低于行业平均水平,截至3月31日,医疗器械行业平均股东户数为2.13万户。从股价来看,2024年2月29日至2024年3月31日,惠泰医疗区间跌幅为6.13%,在此期间股东户数增加381.0户,增幅为12.27%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404251715528b525c6b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404251715528b525c6b&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430476165","title":"惠泰医疗:2024年第一季度净利润约1.40亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2430476165","media":"每日经济新闻","top":-1,"share":"https://www.laohu8.com/m/news/2430476165?lang=zh_cn&edition=full","pubTime":"2024-04-25 17:01","pubTimestamp":1714035661,"startTime":"0","endTime":"0","summary":"惠泰医疗(SH 688617,收盘价:473.94元)4月25日晚间发布一季度业绩公告称,2024年第一季度营收约4.55亿元,同比增加30.2%;归属于上市公司股东的净利润约1.4亿元,同比增加36.48%;基本每股收益2.1元,同比增加36.36%。惠泰医疗的董事长、总经理均是成正辉,男,60岁,学历背景为硕士。截至发稿,惠泰医疗市值为317亿元。文章来源:每日经济新闻原标题:惠泰医疗:2024年第一季度净利润约1.40亿元","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404251709168b52556f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404251709168b52556f&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430427536","title":"惠泰医疗(688617.SH)发布一季度业绩,净利润1.4亿元 同比增加36.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430427536","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2430427536?lang=zh_cn&edition=full","pubTime":"2024-04-25 16:11","pubTimestamp":1714032669,"startTime":"0","endTime":"0","summary":"智通财经APP讯,惠泰医疗(688617.SH)发布2024年一季度报告,报告期内公司实现营业收入4.55亿元,同比增加30.2%;归属于上市公司股东的净利润1.4亿元,同比增加36.48%;归属于上市公司股东的扣除非经常性损益的净利润1.37亿元,同比增加51.59%;基本每股收益2.1元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1109709.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2429171615","title":"医疗耗材概念盘中拉升,惠泰医疗涨2.80%","url":"https://stock-news.laohu8.com/highlight/detail?id=2429171615","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2429171615?lang=zh_cn&edition=full","pubTime":"2024-04-24 10:09","pubTimestamp":1713924575,"startTime":"0","endTime":"0","summary":"04月24日,医疗耗材概念盘中拉升,截至10点09分,医疗耗材概念整体指数上涨0.51%,报900.970点。从个股上来看,该概念的成分股中,惠泰医疗涨2.80%,塞力医疗、开开实业、维力医疗涨幅居前。从资金上来看,截止发稿,医疗耗材概念概念主力净流入为-1425.15万,其中乐普医疗受到资金热捧,主力净流入1057.44万;拉长时间线来看,该板块近20日主力资金净流入-14.04亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240424100935861e85b7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240424100935861e85b7&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2021-01-07","address":"广东省深圳市南山区西丽街道松坪山社区松坪山朗山路11号同方信息港B栋601","stockEarnings":[{"period":"1week","weight":0.0806},{"period":"1month","weight":0.1766},{"period":"3month","weight":0.2915},{"period":"6month","weight":0.4188},{"period":"1year","weight":0.3878},{"period":"ytd","weight":0.2965}],"companyName":"深圳惠泰医疗器械股份有限公司","boardCode":"AI0035","perCapita":"19179股","boardName":"专用设备制造业","registeredCapital":"6686万元","compareEarnings":[{"period":"1week","weight":0.0274},{"period":"1month","weight":0.0209},{"period":"3month","weight":0.1134},{"period":"6month","weight":0.0317},{"period":"1year","weight":-0.0657},{"period":"ytd","weight":0.0437}],"survey":" 深圳惠泰医疗器械股份有限公司的主营业务为心血管介入医疗器械的研发、生产和销售;主要产品是电生理、冠脉通路、外周血管介入、非血管介入医疗器械。公司的电生理电极导管和射频消融电极导管均为国内首个获批上市的国产产品,先发优势助力公司成为国内电生理市场中国生产厂商的龙头企业。","serverTime":1714646303773,"listedPrice":74.46,"stockholders":"3486人(较上一季度增加12.27%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"惠泰医疗(688617)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供惠泰医疗(688617)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"惠泰医疗,688617,惠泰医疗股票,惠泰医疗股票老虎,惠泰医疗股票老虎国际,惠泰医疗行情,惠泰医疗股票行情,惠泰医疗股价,惠泰医疗股市,惠泰医疗股票价格,惠泰医疗股票交易,惠泰医疗股票购买,惠泰医疗股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"惠泰医疗(688617)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供惠泰医疗(688617)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}